GlassScriptPhysician profile
Matthew A Goldstein
NPI 1598967325
$130,370.10
in general payments reported to CMS, 2019-2025
25 companies · $21K in 2025
The $21K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $21K · 2021: $11K · 2022: $18K · 2023: $11K · 2024: $15K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $7,063 · Food and Beverage: $6,712 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,800 · Honoraria: $3,600 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,000.50 |
| Travel and Lodging | $7,062.86 |
| Food and Beverage | $6,711.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,800.00 |
| Honoraria | $3,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36,209.09 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Arctic Front Advance |
| Janssen Pharmaceuticals, INC | $22,745.05 | 2019-2022 | |
| Medtronic Vascular, INC. | $18,774.20 | 2019-2020 | |
| Abbott Laboratories | $14,813.22 | 2019-2025 | Aveir, Viewmate, Jot Dx |
| Boston Scientific Corporation | $12,166.85 | 2019-2025 | Watchman Access System, Farapulse, Ingevity+ |
| Biotronik INC. | $10,358.54 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Biomonitor |
| Infobionic, INC | $8,662.50 | 2022-2025 | Mome Device |
| Impulse Dynamics (USA) INC. | $5,153.12 | 2019-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $313.38 | 2019-2024 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Pfizer INC. | $221.13 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $153.83 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $113.18 | 2019-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $105.66 | 2019-2025 | |
| Cvrx, INC. | $95.83 | 2023 | Barostim Neo System |
| Lilly USA, LLC | $77.21 | 2025 | Zepbound |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $74.59 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.23 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.80 | 2021-2024 | Jardiance |
| Imperative Care, INC | $57.30 | 2025 | Zoom Reperfusion Catheter |
| Becton, Dickinson and Company | $54.45 | 2025 | Hemosphere |
| Shockwave Medical, INC | $31.65 | 2025 | |
| Tactile Systems Technology INC | $21.11 | 2025 | Flexitouch Plus, Nimbl |
| Philips North America LLC | $17.04 | 2025 | Labosys |
| Actelion Pharmaceuticals US, INC. | $14.28 | 2019 | |
| Merit Medical Systems INC | $10.86 | 2025 | Prelude Introducers |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.